A-share pharmaceutical retail sector saw a short-term surge, with Renmin Tongtai hitting the daily limit, Hefu China previously achieving six consecutive daily limit increases, and Shuyu Pingmin, Jianfa Zhixin, Luyan Pharmaceutical, Laobaixing, and Huaren Health following suit.